Cite
MLA Citation
Priya Kumthekar et al.. “CMET-22. INTRATHECAL (IT) TRAZTUZUMAB (T) FOR THE TREATMENT OF LEPTOMENINGEAL METASTASES (LM) IN PATIENTS (PTS) WITH HUMAN EPIDERMAL GROWTH FACTOR RECEPTOR 2-POSITIVE (HER2+) CANCER: A MULTICENTER PHASE 1/2 STUDY.” Neuro-oncology, vol. 20, n.d., p. vi58. http://access.bl.uk/ark:/81055/vdc_100095322540.0x000015